THE DIAGNOSIS OF POLYCYTHEMIA
Authors: William Dameshek, Henry H. Henstell
Journal: Annals of Internal Medicine (1940)

Article1 February 1940THE DIAGNOSIS OF POLYCYTHEMIAWILLIAM DAMESHEK, M.D., HENRY H. HENSTELL, M.D.WILLIAM DAMESHEK, M.D., HENRY H. HENSTELL, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-13-8-1360 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptPolycythemia vera is a relatively "new" disease. Although first described by Vaquez1in 1892, it did not become generally known until after the appearance of Osler's articles in 1903 and 1908.2, 3Since that time, it has usually been considered a rarity; evidence for this is present in the very few references to the disease from year to year in the world's literature. Among the various hematological conditions listed in the Quarterly Cumulative Index Medicus, polycythemia ranks close to the last. Even in the last few years, with the evident great interest in the various disorders of the blood, the...References1. VAQUEZ H: Sur une forme spèciale de cyanose s'accompagnant d'hyperglobulie excessive et persistente, Compt. rend. Soc. de biol., 1892, xliv, 384. Google Scholar2. OSLER W: Chronic cyanosis, with polycythemia and enlarged spleen: a new clinical entity, Am. Jr. Med. Sci., 1903, cxxvi, 187. CrossrefGoogle Scholar3. OSLER W: A clinical lecture on erythraemia (polycythemia with cyanosis; Maladie de Vaquez), Lancet, 1908, i, 143. Google Scholar4. HARROP GA: Polycythemia, Medicine, 1928, vii, 291. Google Scholar5. REZNIKOFFFOOTBETHEA PNCJM: Etiologic and pathologic factors in polycythemia vera, Am. Jr. Med. Sci., 1935, clxxxix, 753. CrossrefGoogle Scholar6. NYGAARDBROWN KKGE: Essential thrombophilia; report of 5 cases, Arch. Int. Med., 1937, lix, 82. CrossrefGoogle Scholar7. BROWNGIFFIN GEHZ: Peripheral arterial disease in polycythemia, Arch. Int. Med., 1930, xlvi, 705. CrossrefGoogle Scholar8. DAMESHEKHENSTELL WHH: The treatment of polycythemia vera by the production of a chronic iron deficiency state, Jr. Clin. Invest., 1937, xvi, 683. Google Scholar9. HADEN RL: The red cell mass in polycythemia in relation to diagnosis and treatment, Am. Jr. Med. Sci., 1938, cxcvi, 493. CrossrefGoogle Scholar10. BRENNER O: Pathology of the vessels of the pulmonary circulation, Arch. Int. Med., 1935, lvi, 1189. CrossrefGoogle Scholar11a. BLUMGARTGARGILLGILLIGAN HLSLDR: Studies on the velocity of blood flow. XV. The velocity of blood flow and other aspects of the circulation in patients with "primary" and secondary anemia and in two patients with polycythemia vera, Jr. Clin. Invest., 1931, ix, 679. b. ALTSCHULE, MARK A.: Personal communication. CrossrefGoogle Scholar12a. CHRISTIAN HA: Nervous symptoms of polycythemia vera, Am. Jr. Med. Sci., 1917, cliv, 547. b. BROCKBANK, T. W.: Neurologic aspects of polycythemia vera, Am. Jr. Med. Sci., 1929, clxxviii, 209. CrossrefGoogle Scholar13. BOYD W: The relationship of polycythemia to duodenal ulcer, Am. Jr. Med. Sci., 1931, clxxxii, 741. Google Scholar14. LUCAS WS: Erythremia, or polycythemia rubra vera with leukemic blood picture, Jr. Am. Med. Assoc., 1929, xcii, 1825. Google Scholar15. GAISBÖCK F: Die Bedeutung der Blutdruckmessung, Verhandl. d. Kong. f. inn. Med., 1904, xxi, 97. Google Scholar16. GRAM HC: Albuminuria in polycythemia and its nature during treatment, Ugeskr. f. Laeger., 1932, xciv, 262. Google Scholar17. BLAKE D: Student's Thesis, Harvard Medical School, 1937. Google Scholar18. ROWNTREEBROWN LGGE: The volume of the blood and plasma in health and disease, 1929, W. B. Saunders Co., Philadelphia and London. Google Scholar19. BROWNGIFFIN GEHZ: Capillaries and blood volume in polycythemia, Am. Jr. Med. Sci., 1923, clxvi, 489. CrossrefGoogle Scholar20. BLISS TL: Basal metabolism in polycythemia vera, ANN. INT. MED., 1929, ii, 1155. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Boston, Massachusetts*Received for publication December 30, 1938.From the Medical Service and Hematology Laboratory, Beth Israel Hospital, Boston.†Charlton Fellow in Medicine, Tufts College Medical School (1936-37).Aided by a grant from the Charlton Fund, Tufts College Medical School. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byNovel European Asiatic Clinical, Laboratory, Molecular and Pathobiological (2015-2020 CLMP) criteria for JAK2V617F trilinear polycythemia vera (PV), JAK2exon12 PV and JAK2V617F, CALR and MPL515 thrombocythemias: From Dameshek to Constantinescu-Vainchenker, Kralovics and MichielsEuropean Clinical Laboratory, Molecular and Pathological (ECMP) criteria for prefibrotic JAK2V617F-Thrombocythemia and Polycythemia Vera versus MPL515- and CALR-Thrombocythemia and Myelofibrosis: From Dameshek to Michiels 1950-2018Novel Clinical, Laboratory, Molecular and Pathological (2018 CLMP) Criteria for the Differential Diagnosis of three Distinct JAK2, CALR and MPL Mutated Myeloproliferative Neoplasms: The Role of Driver Mutation Analysis and Bone Marrow HistologyExtension of 2016 World Health Organization (WHO) Classification into a New Set of Clinical, Laboratory, Molecular, and Pathological Criteria for the Diagnosis of Myeloproliferative Neoplasms: From Dameshek to Vainchenker, Green, and KralovicsAspirin cures erythromelalgia and cerebrovascular disturbances in JAK2-thrombocythemia through platelet-cycloxygenase inhibitionChanging Concepts of Diagnostic Criteria of Myeloproliferative Disorders and the Molecular Etiology and Classification of Myeloproliferative Neoplasms: From Dameshek 1950 to Vainchenker 2005 and BeyondTraining and Detraining Effects on Functional Fitness after a Multicomponent Training in Older WomenErythromelalgia: Review of clinical characteristics and pathophysiologyPrimary polycythaemia presenting with choreaDrug Therapy of HypertensionImportance of the hematocrit as a risk factor in cerebral infarction.Chorea, polycythaemis, and cyanotic heart disease.Biophysical Behavior of Red Cells in SuspensionsMagenDie Therapie der Polycythaemia rubra vera Vaquez-OslerDie Therapie der Polycythaemia rubra vera Vaquez-OslerPLATELET ADHESIVENESS IN POLYCYTHAEMIA RUBRA VERAPolycythemiaSURGICAL BLEEDING IN POLYCYTHEMIA VERA*WAVE FORM ANALYSIS OF GASTROINTESTINAL PRESSURE DYNAMICSSurgery in Polycythemia VeraNeurologic Complications of PolycythemiaALLEN SILVERSTEIN, M.D., HARRIET GILBERT, M.D., LOUIS R. WASSERMAN, M.D., F.A.C.P.Herz und Kreislauf bei Erkrankungen des Blutes und der blutbildenden OrganePOLYCYTHEMIA VERA. II. COURSE AND THERAPY*PAUL CALABRESI, M.D., OVID O. MEYER, M.D., F.A.C.P.HOST FACTORS IN POLYCYTHEMIA VERA*ALBERT DAMON, M.D., Ph.D., DONALD A. HOLUB, M.D.Neurologic Manifestations of Chronic Pulmonary InsufficiencyAspectos neurológicos da policitemia veraIS PRIMARY HEMORRHAGIC THROMBOCYTHEMIA A CLINICAL MYTH?*WILLIAM R. MCCABE, M.D., ROBERT M. BIRD, M.D., ROBERT A. MCLAUGHLIN, M.D.Laboratory Diagnosis of Polycythemia and AnemiaBlood dyscrasia in otolaryngologyTreatment of Polycythemia Vera with large Venesections and Plasma Transfusions. 1 February 1940Volume 13, Issue 8Page: 1360-1387KeywordsBloodHematology and oncologyMedical servicesPolycythemiaPolycythemia veraResearch laboratories ePublished: 1 December 2008 Issue Published: 1 February 1940 PDF downloadLoading ...